Holen Sie sich die Stockscreener-App
8.04
1.35%
-0.11
Handel nachbörslich:
8.04
Schlusskurs vom Vortag:
$8.15
Offen:
$8.16
24-Stunden-Volumen:
252.78K
Relative Volume:
3.23
Marktkapitalisierung:
$105.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+60.48%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$7.72
$8.55
1-Wochen-Bereich:
$4.90
$9.04
52-Wochen-Spanne:
$4.17
$9.04
Linkers Industries Ltd Stock (LNKS) Company Profile
Vergleichen Sie LNKS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNKS
Linkers Industries Ltd
|
8.04 | 105.73M | 0 | 0 | 0 | 0.00 |
|
VRT
Vertiv Holdings Co
|
120.04 | 45.06B | 7.53B | 581.40M | 1.08B | 1.50 |
|
HUBB
Hubbell Inc
|
426.80 | 22.91B | 5.64B | 751.80M | 730.00M | 13.88 |
|
NVT
Nvent Electric Plc
|
69.55 | 11.46B | 3.82B | 576.00M | 581.30M | 3.41 |
|
AYI
Acuity Brands Inc
|
302.70 | 9.38B | 3.84B | 422.60M | 555.20M | 13.44 |
|
BE
Bloom Energy Corp
|
24.12 | 5.51B | 1.26B | -129.51M | -334.40M | -0.56 |
Linkers Industries Ltd Aktie (LNKS) Neueste Nachrichten
ADCs: Leading With The Linker - BioProcess Online
Stock market news: Dream Vision surges 39.68%, Osaka Yuka up 37.72%, as Nippon Denkai drops 19.57% in mid-day volatility - Business Upturn
Linkers Industries LimitedClass A Ordinary Shares (LNKS) Latest News & Price - InvestorPlace
Linkers Industries announces pricing of initial public offering and listing on Nasdaq - MSN
U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations - The Manila Times
Linkers Industries Limited Announced Closing of Initial Public Offering - EIN News
Linkers Industries Debuts on Nasdaq, Raises $7.6M in Wire Harness Manufacturing IPO - StockTitan
LNKS IPO NewsMalaysian cable manufacturer Linkers Industries prices downsized US IPO at the $4 low end - Renaissance Capital
Linkers Industries Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq - The Manila Times
Linkers Industries Limited Prices 1.9M Share IPO at $4/sh - Investing.com Canada
LNKSLinkers Industries Limited Latest Stock News & Market Updates - StockTitan
TCL Electronics Approves Key Agreements at EGM - MSN
Top 10 startups in Manufacturing Tech in Saudi Arabia in Nov, 2024 - Tracxn
Antibody Drug Conjugates (ADC) Industry Report 2024 - GlobeNewswire
Antibody Drug Conjugates Industry Report (2024-2032) - GlobeNewswire
Antibody Drug Conjugates Market Size Potential to Reach USD 39 Billion by 2032 By IMIR Market Research Pvt. Ltd. - GlobeNewswire
OS Therapies Accepted Into Johnson & Johnson InnovationJLABS - Yahoo Finance
Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market Report Scope - InsightAce Analytic
Era of ADCs: Pharma companies innovate to stand out in a buzzing market - Pharmaceutical Technology
Delocalized Orbitals over Metal Clusters and Organic Linkers Enable Boosted Charge Transfer in Metal–Organic Framework for Overall CO2 Photoreduction - Wiley Online Library
Textile Coatings Market Size, Share & Growth Report, 2030 - Grand View Research
Crosslinking Agent Market Size, Share & Growth Report 2030 - Grand View Research
Antibody Drug Conjugates Market Size to Reach USD 28.61 Bn by 2033 - BioSpace
Design of fusion enzymes for biocatalytic applications in aqueous and non-aqueous media - Frontiers
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PR Newswire
Pheon rides wave of ADC interest with $120M financing - BioPharma Dive
This Innovator Bridges Continents Through Sustainable Tourism Initiatives - Elle Canada
Initial Public Offering (IPO) News Live Feed - StockTitan
Antibody-Drug Conjugates (ADC) Market, Industry Trends, Pipeline Products and Challenges - GlobalData
KDDF bolsters the development of innovative cancer therapies - Nature.com
A smart lighting masterpiece: Nanoleaf Canvas review - Whats The Best
Manufacturing Challenges of Therapeutic Antibody–Drug Conjugates - BioProcess Insider
Fourteen biotech companies spearheading the antibody drug conjugate industry - Labiotech.eu
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development - PR Newswire
US agency nixes Seagen patent, handing Daiichi Sankyo a win in long-running Enhertu entanglement - FiercePharma
Peptide Synthesis Market 2032: Size & Growth Forecasts - Vantage Market Research
The top 5 ADC startups favoured by venture capital investors - BioPharma-Reporter.com
Linkers Industries: LNKS IPO, IndustrialsMalaysian manufacturer and supplier of wire/cable harnesses. - Renaissance Capital
Samsung Bioepis, Intocell partner for ADC drug development - BioWorld Online
When to buy index-linked bonds - Investors Chronicle
ADC (Antibody Drug Conjugates) Markets, 2035 - Yahoo Finance
Antibody Drug Conjugates (ADC) Market worth $19.8 billion | MarketsandMarkets - PR Newswire
The Rise of Antibody–Drug Conjugates and Related Modalities: Innovations and Partnerships Lead the Way - BioProcess Insider
Thompson Street Capital Partner’s Vector Laboratories Acquires Quanta BioDesign - Business Wire
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers - Business Wire
Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker - Frontiers
Revenge of the ADCs - The Medicine Maker
Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry - ACS Publications
Companies are being called on to make their supply chains more resilient and transparent - global.toshiba
Next-generation ADCs: better oncology treatments through innovation - European Pharmaceutical Manufacturer
Finanzdaten der Linkers Industries Ltd-Aktie (LNKS)
Es liegen keine Finanzdaten für Linkers Industries Ltd (LNKS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):